Regulatory Framework

All aspects within the medicines development process are subject to various degree of regulation. In this section, you can learn more about the legal framework, guidelines, Health Authorities' attitudes and requirements that have a significant influence on the development process and its success rate. As patient advocates and researches, it is important to understand the basic principles of regulatory affairs in order to be able to interact proactively with regulatory authorities.



In this section, you can access a series of webcasts from the EURORDIS Summer School on the current European regulatory framework for medicines development, storage and distribution.  You can also learn about how regulatory authorities assess quality, safety and efficacy.



This section contains slide presentations from the EURORDIS Summer School on patient involvement in benefit risk at the European Medicines Agency, how the Pharmaceutical Risk Assessment Committee evaluates medicinal products.

The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseasesRare Disease International Bringing together patients, families and experts to share experiences in a moderated multi-language forum. RareConnect The Rare Barometer Programme is a EURORDIS initiative that carries out surveys to transform rare disease patients' experiences into figures and facts that can be shared with decision-makers.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases